ATG16L1 and pathogenesis of urinary tract infections by Wang, Caihong et al.




ATG16L1 and pathogenesis of urinary tract
infections
Caihong Wang
Washington University School of Medicine in St. Louis
Jane W. Symington
Washington University School of Medicine in St. Louis
Indira U. Mysorekar
Washington University School of Medicine in St. Louis
Follow this and additional works at: http://digitalcommons.wustl.edu/open_access_pubs
This Open Access Publication is brought to you for free and open access by Digital Commons@Becker. It has been accepted for inclusion in Open
Access Publications by an authorized administrator of Digital Commons@Becker. For more information, please contact engeszer@wustl.edu.
Recommended Citation


























Autophagy 8:11, 1693–1694; November 2012; © 2012 Landes Bioscience
 AutophAgic puNctum AutophAgic puNctum
Punctum to: Wang C, Mendonsa GR, Symington 
JW, Zhang Q, Cadwell K, Virgin HW, et al. 
Atg16L1 deficiency confers protection from 
uropathogenic Escherichia coli infection in vivo. 
Proc Natl Acad Sci U S A 2012; 109:11008–13; 
PMID:22715292; http://dx.doi.org/10.1073/
pnas.1203952109
Keywords: Atg16L1, autophagy, urinary 
tract infections, uropathogenic E. coli, 
bladder, Atg5, Crohn disease
Abbreviations: UTI, urinary tract infec-
tions; UPEC, uropathogenic E. coli; 
ATG16L1HM mice, ATG16L1 hypo-
morphic mice; CD, Crohn disease; 





*Correspondence to: Indira U. Mysorekar; 
Email: indira@wustl.edu
Autophagy is generally considered to be antipathogenic. The autophagy 
gene ATG16L1 has a commonly occurring 
mutation associated with Crohn disease 
(CD) and intestinal cell abnormali-
ties. Mice hypomorphic for ATG16L1 
(ATG16L1HM) recreate specific features 
of CD. Our recent study shows that the 
same ATG16L1HM mice that are suscepti-
ble to intestinal inflammatory disease are 
protected from urinary tract infections 
(UTI), a common and important human 
disease primarily caused by uropatho-
genic E. coli (UPEC). UPEC colonize 
the bladder and exhibit both luminal and 
intra-epithelial stages. The host responds 
by recruiting innate immune cells and 
shedding infected epithelial cells to clear 
infection. Despite these countermea-
sures, UPEC can persist within the blad-
der epithelium as membrane-enclosed 
quiescent intracellular reservoirs (QIRs) 
that can seed recurrent UTI. The mech-
anisms of persistence remain unknown. 
In this study, we show that ATG16L1 
deficiency protects the host against acute 
UTI and UPEC latency. ATG16L1HM 
mice clear urinary bacterial loads more 
rapidly and thoroughly due to ATG16L1-
deficient innate immune components. 
Furthermore, ATG16L1HM mice exhibit 
superficial urothelial cell-autonomous 
architectural aberrations that also result 
in significantly reduced QIR numbers. 
Our findings reveal a host-protective 
effect of ATG16L1 deficiency in vivo 
against a common pathogen.
Recent reviews highlight the complex 
interplay between autophagy and micro-
bial adaptations governing host-patho-
gen interaction outcomes. Autophagic 
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degradation of intracellular pathogens is a 
significant host defense. However, patho-
gens employ many strategies to evade or 
subvert the autophagy machinery for 
survival including retarding the matura-
tion of autophagosomes, impairing fusion 
with lysosomes, escaping to the cytosol, 
and adapting to survive and replicate 
within the autophagosomal or lysosomal 
compartment. Recently, for example, 
Kim and coworkers demonstrated the 
importance of host autophagy in modu-
lating effective antimicrobial responses 
to Mycobacterium tuberculosis, and the 
Celli group showed that Brucella subverts 
autophagy complexes to facilitate its intra-
cellular cycle. However, little is known 
about how UPEC interact with autoph-
agy. We previously showed that UPEC 
are enclosed in LAMP1-positive vesicles 
(QIRs) that resemble LAMP1-positive 
spacious Listeria-containing phagosomes 
(SLAPs) described by Brumell’s group. 
In this study, we show that UPEC are 
also targeted by the ATG16L1, LC3, and 
SQSTM1/p62 proteins. Our findings for 
UPEC, thus, resemble other studies on 
intracellular recognition of Salmonella 
enterica serovar Typhimurium, Shigella 
flexneri, and Listeria monocytogenes. We 
also find UPEC in double-membranous 
structures in transmission electron micro-
graphs of infected bladders (Fig. 1).
The Virgin group had previously dem-
onstrated that ATG16L1HM mice develop 
intestinal abnormalities in Paneth cells. 
Our work shows that ATG16L1 deficiency 
induces multiple, baseline abnormali-
ties in cellular components that UPEC 
encounter during infection. ATG16L1-
deficient cells dramatically accumulate 
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cytokine production. Thus, an ATG16L1 
deficiency-induced hyperinflammatory 
response may help clear the infection by 
countering UPEC’s ability to dampen 
innate immune responses.
It is important to determine if the pro-
tection we observed is ATG16L1-specific 
or represents a general effect of the auto-
phagy pathway on UTI pathogenesis. The 
autophagy machinery comprises many 
essential proteins including ATG5, ATG7 
and ATG12. We demonstrated that innate 
immune cell-specific knockdown of Atg5 
induces a similar protective phenotype as 
that induced by ATG16L1 deficiency, sug-
gesting that UPEC may hijack multiple 
autophagy components to colonize and 
persist in the urinary tract.
A polymorphism in ATG16L1 associ-
ated with CD can be found in up to 50% 
of individuals in certain populations. It 
is unclear why a seemingly unfavorable 
allelic variant of ATG16L1 would occur 
at such high frequency. One explanation 
is that the alleles were originally selected 
for a beneficial property such as protec-
tion against chronic or recurrent infec-
tious diseases. Our results demonstrating 
that ATG16L1 mutation can confer pro-
tection against UTIs could explain why 
mutant alleles are unexpectedly frequent: 
protection against UTIs could be a mech-
anism to counter the negative selection 
imposed by the inflammation-promoting 
effects of the ATG16L1 mutation. A bet-
ter understanding of the link between 
autophagy, latency, and inflammation 
could lead to therapeutic approaches, for 
example by targeting ATG16L1 or auto-
phagy in general to treat recurrent UTI. 
Thus, the use of inhibitors of autophagy 
or ATG16L1 to eliminate latent bacterial 
reservoirs may have substantial clinical 
benefits to combat refractory and recur-
rent UTIs, because conventional antibi-
otics are unable to penetrate urothelial 
barriers to clear bacteria sequestered as 
QIRs.
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hyperinflammatory response by removing 
the restriction on IL1B/IL-1β signaling 
cascades and IL-6 production. Similarly, 
Saitoh et al., showed that ATG16L1-
deficient macrophages produce high 
amounts of the inflammatory cytokines 
IL1B and IL18. In our study, we observed 
significantly increased levels of IL-6 and 
IL1A/IL-1α in infected ATG16L1HM mice 
relative to controls. Furthermore, our 
findings demonstrated that ATG16L1-
deficient hematopoietic cells, especially 
neutrophils and macrophages, contrib-
ute critically to mounting a hypervigi-
lant innate immune response, which 
likely promotes the rapid clearance of 
extracellular UPEC. Cadwell and Virgin 
previously demonstrated enhanced tran-
scription of pro-inflammatory cytokines 
in aberrant Paneth cells of ATG16L1HM 
mice. In the setting of CD and the pres-
ence of commensal bacteria, elevated pro-
inflammatory cytokine levels induced by 
ATG16L1 deficiency lead to intestinal 
pathology, which is detrimental to the 
host. However, in the ATG16L1-deficient 
urinary tract, the elevated proinflam-
matory cytokine levels may have a ben-
eficial effect, as UPEC has been shown 
previously to inhibit proinflammatory 
UPEC receptor (UPK1A/UP1a). The 
aberrations are intrinsic to ATG16L1-
deficient epithelial cells, because transfer-
ring ATG16L1-deficient hematopoietic 
cells does not induce them in wild-type 
epithelium, and even newly regenerating 
ATG16L1-deficient superficial cells show 
the same accumulations. Our study shows 
that UPEC are less able to occupy their 
intracellular niches to persist as QIRs in 
the ATG16L1HM epithelium. We propose, 
thus, that UPEC may normally utilize 
ATG16L1 and possibly other autoph-
agy proteins to establish latency, thus 
ATG16L1 deficiency can be protective in 
this regard. In other words, UPEC may 
need the normal autophagic machinery 
to persist. The mechanisms underlying 
how UPEC avoid degradation or survive 
in the autophagosomal niches remain to 
be elucidated.
Autophagy plays multiple roles in both 
innate and adaptive immunity. Recent 
studies have suggested that autophagy 
governs the balance between defend-
ing against pathogens and modulating 
innate immunity to prevent excessive 
inflammatory responses and inflamma-
some signaling. Lee et al., demonstrated 
that ATG16L1 deficiency leads to a 
Figure 1. upEc enclosed within a double-membraned autophagosomal structure. tEm of blad-
der tissue from Atg16L1hm mice 14 d post-infection, depicting upEc (arrowheads) enclosed in a 
double-membraned autophagosomal structure (arrow). Bar: 1 μm.
